| Route of administration | Host | Pros | Cons |
| Edible | Plant | Mucosal and systemic immunities, scale-up production, stable transformation, transient transformation, no antigen purification, long-term storage at RT, antigen bioencapsulation, no microbial contaminations | Lack of a proper dosing strategy, improper glycosylation, low antigen expression yields, unstable antigen expression | Algae | Mucosal and systemic immunities, scale-up production (bioreactors), fast biomass accumulation, easy stable transformation, antigen bioencapsulation, long-term storage at RT | Improper glycosylation, low antigen expression yields | Insect | Mucosal and systemic immunities, cotranslational modifications, posttranslational modifications, high antigen expression yields, antigen bioencapsulation, stable transformation, transient transformation, high immunogenicity | Improper glycosylation; further studies are needed; cultural barrier | Yeast | Mucosal and systemic immunities, posttranslational modifications, antigen bioencapsulation, high immunogenicity | Inaccurate glycosylation; further studies are needed | LAB | Mucosal and systemic immunities, antigen bioencapsulation, high immunogenicity | Possible transfer of antibiotic selection markers |
| Intradermal | ā | Mucosal and systemic immunities, no systemic side effects, dose sparing, storage at room temperature | Trained personnel for administration, local reactogenicity |
|
|